Skip to content

6-KAccepted Aug 10, 4:17 PM ET

Agomab Therapeutics NV 6-K

AGMBAgomAb Therapeutics NV

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:17 PM

Aug 10, 2026

Filed

Aug 10, 2026

Documents

33

Size

5.4 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.